In Vitro Diagnostics Company
Appears in 1 story · Last updated Aug 25, 2026
As of August 2026: Developer of the first FDA-cleared test, now expanding in Europe
Alzheimer's diagnosis used to require a $5,000 brain scan or a painful spinal tap. As of August 2026, the FDA has cleared four blood tests for the disease, from Roche's Elecsys pTau217 to C2N's PrecivityAD2, approved for adults as young as 40.
Updated Aug 25
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
